Status
Conditions
Treatments
About
This primary objective of this study is to describe the incidence of RSV infection in adult hematopoietic cell transplant recipients OR hematological malignancies patients in Tianjin HI.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Aged ≥ 18 years old. 2) Receiving hematopoietic stem cell transplantation; OR being diagnosed with hematological malignancies (including but not limited to leukemia, lymphoma, and multiple myeloma) and receiving chemotherapy.
New onset of respiratory symptoms; OR exacerbation of existing chronic respiratory symptoms (such as previously diagnosed chronic runny nose, seasonal allergies, chronic lung disease, etc.).
Willing to sign an informed consent form, able to understand and willing to follow the study protocol.
Exclusion criteria
Loading...
Central trial contact
Erlie Jiang, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal